Vir Biotechnology Inc (VIR)

Precedente Chiudi:

$8.37

Aprire:

$8.36

Volume 24 ore:

1.04M

Capitalizzazione di mercato:

$1.15B

Reddito:

$39.49M

Utile/perdita netta:

$-615.06M

Rapporto P/E:

-1.8842

EPS:

-4.49

Flusso di cassa netto:

$-800.36M

1 W Prestazione:

+4.06%

1M Prestazione:

-16.49%

6M Prestazione:

+5.09%

1 anno Prestazione:

-66.36%

Intervallo 1D:

$8.20

$8.4855

Portata 52W:

$7.61

$27.48

Vir Biotechnology Inc Stock (VIR) Company Profile

Nome

Vir Biotechnology Inc

Settore

Healthcare (1191)

Industria

Biotechnology (682)

Telefono

415-906-4324

Indirizzo

499 Illinois Street, Suite 500, San Francisco, CA

Dipendente

237

Cinguettio

@Vir_Biotech

Prossima data di guadagno

2024-05-29

Ultimi documenti SEC

VIR's Discussions on Twitter

Vir Biotechnology Inc Stock (VIR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-01-29	Downgrade	JP Morgan	Overweight → Neutral
2023-09-08	Downgrade	BofA Securities	Buy → Neutral
2023-03-06	Aggiornamento	JP Morgan	Neutral → Overweight
2023-02-21	Aggiornamento	Goldman	Neutral → Buy
2023-01-27	Aggiornamento	Morgan Stanley	Underweight → Equal-Weight
2022-09-14	Iniziato	SVB Leerink	Outperform
2022-09-09	Iniziato	Morgan Stanley	Underweight
2022-03-03	Aggiornamento	Robert W. Baird	Underperform → Neutral
2021-12-21	Downgrade	Robert W. Baird	Neutral → Underperform
2021-10-25	Aggiornamento	JP Morgan	Underweight → Neutral
2021-09-22	Downgrade	Goldman	Buy → Neutral
2021-06-04	Ripresa	Robert W. Baird	Neutral
2021-01-27	Downgrade	JP Morgan	Neutral → Underweight
2021-01-20	Reiterato	H.C. Wainwright	Buy
2020-10-05	Iniziato	BofA Securities	Buy
2020-09-14	Aggiornamento	Goldman	Neutral → Buy
2020-09-11	Aggiornamento	JP Morgan	Underweight → Neutral
2020-08-20	Iniziato	Needham	Buy
2020-03-19	Downgrade	JP Morgan	Neutral → Underweight
2020-03-13	Downgrade	Goldman	Buy → Neutral
2020-02-27	Downgrade	Robert W. Baird	Neutral → Underperform
2020-02-04	Downgrade	JP Morgan	Overweight → Neutral
2019-11-14	Iniziato	Robert W. Baird	Neutral
2019-11-05	Iniziato	Barclays	Overweight
2019-11-05	Iniziato	Cowen	Outperform
2019-11-05	Iniziato	Goldman	Buy
2019-11-05	Iniziato	JP Morgan	Overweight

Mostra tutto

Vir Biotechnology Inc Borsa (VIR) Ultime notizie

What Makes Vir Biotechnology (VIR) a New Buy Stock

Zacks Investment Research

Assessing Vir Biotechnology: Insights From 5 Financial Analysts

Benzinga

Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday

Benzinga

Wall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 186.41%: Here's is How to Trade

Zacks Investment Research

Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research

Vir Biotechnology Inc Azioni (VIR) Dati Finanziari

Vir Biotechnology Inc (VIR) Reddito 2024

Vir Biotechnology Inc (VIR) Reddito netto 2024

Vir Biotechnology Inc (VIR) Flusso di cassa 2024

Vir Biotechnology Inc (VIR) Utile per azione 2024

Vir Biotechnology Inc Azioni (VIR) insider trading